667097787	667097787	CD	B-NP	O
|	|	NN	I-NP	O
ACH	ACH	NN	I-NP	O
|	|	NN	I-NP	O
48604344	48604344	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
613851	613851	CD	B-NP	O
|	|	CC	I-NP	O
11/16/1997	11/16/1997	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
NEW	NEW	NNP	I-NP	I-protein
ATRIAL	ATRIAL	NNP	I-NP	I-protein
FIBRILLATION	FIBRILLATION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/23/1997	10/23/1997	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/21/1997	8/21/1997	CD	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
76	76	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
woman	woman	NN	I-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
two	two	CD	I-NP	O
vessel	vessel	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
on	on	IN	B-PP	O
3/10/97	3/10/97	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
on	on	IN	B-PP	O
5/4/97	5/4/97	CD	B-NP	O
to	to	TO	B-PP	O
Diand	Diand	NNP	B-NP	O
Leb	Leb	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
And	And	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
epigastric	epigastric	JJ	B-NP	O
discomfort	discomfort	NN	I-NP	O
and	and	CC	O	O
recurrent	recurrent	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
Landso	Landso	NNP	B-NP	O
Souwalt	Souwalt	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
history	history	NN	I-NP	O
dates	date	NNS	I-NP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
1995	1995	CD	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Kassi	Kassi	NNP	B-NP	O
Rehabilitation	Rehabilitation	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
asthma	asthma	NN	I-NP	O
flare	flare	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
she	she	PRP	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
CKs	CK	NNS	I-NP	B-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

An	An	DT	B-NP	O
exercise	exercise	NN	I-NP	O
test	test	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
showed	show	VBD	B-VP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
eight	eight	CD	B-NP	O
minutes	minute	NNS	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
Bruce	Bruce	NNP	I-NP	O
protocol	protocol	NN	I-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
leads	lead	NNS	B-NP	O
2	2	CD	I-NP	O
,	,	,	I-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
F	F	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
MIBI	MIBI	NNP	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
reversible	reversible	JJ	I-NP	O
defect	defect	NN	I-NP	O
inferiorly	inferiorly	RB	B-ADVP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
managed	manage	VBN	I-VP	O
medically	medically	RB	B-ADVP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
February	February	NNP	B-NP	O
of	of	IN	B-PP	O
1996	1996	CD	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
again	again	RB	I-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Lita	Lita	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Prilosec	Prilosec	NNP	B-NP	O
for	for	IN	B-PP	O
presumed	presume	VBN	B-NP	O
gastroesophageal	gastroesophageal	JJ	I-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
September	September	NNP	B-NP	O
of	of	IN	B-PP	O
1996	1996	CD	B-NP	O
an	an	DT	B-NP	O
exercise	exercise	NN	I-NP	O
Thallium	Thallium	NN	I-NP	O
test	test	NN	I-NP	O
showed	show	VBD	B-VP	O
she	she	PRP	B-NP	O
went	go	VBD	B-VP	O
eight	eight	CD	B-NP	O
minutes	minute	NNS	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
Bruce	Bruce	NNP	I-NP	O
protocol	protocol	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
125	125	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
170/80	170/80	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
ECG	ECG	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
stopped	stop	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
3/30/97	3/30/97	CD	B-NP	O
through	through	IN	B-PP	O
3/5/97	3/5/97	CD	B-NP	O
she	she	PRP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
which	which	WDT	B-NP	O
radiated	radiate	VBD	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
shoulders	shoulder	NNS	I-NP	O
and	and	CC	I-NP	O
jaw	jaw	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
presentation	presentation	NN	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
ECG	ECG	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
showed	show	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
T-waves	T-wave	NNS	B-NP	O
in	in	IN	B-PP	O
V1	V1	NN	B-NP	O
and	and	CC	I-NP	O
V2	V2	NN	I-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
with	with	IN	B-PP	O
slowing	slow	VBG	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
relief	relief	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
ruled	rule	VBD	B-VP	O
in	in	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
CK	CK	NN	I-NP	O
of	of	IN	B-PP	O
473	473	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MB	MB	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
32	32	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-VP	O
Verapamil	Verapamil	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
increased	increase	VBN	B-NP	O
wheezing	wheeze	VBG	I-NP	O
requiring	require	VBG	I-NP	O
nebulizers	nebulizer	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	I-NP	O
that	that	WDT	B-NP	O
had	have	VBD	B-VP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
with	with	IN	B-PP	O
collaterals	collateral	NNS	B-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
circumflex	circumflex	NN	B-NP	O
artery	artery	NN	I-NP	O
with	with	IN	B-PP	O
long	long	RB	B-NP	O
80	80	CD	I-NP	O
to	to	TO	I-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
30	30	CD	B-NP	O
to	to	TO	I-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
ventricle	ventricle	NN	B-NP	O
with	with	IN	B-PP	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
58	58	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
apical	apical	JJ	B-NP	O
akinesis	akinesis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
spontaneously	spontaneously	RB	B-ADVP	O
converted	convert	VBD	B-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Following	Follow	VBG	B-VP	O
catheterization	catheterization	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
agreed	agree	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
but	but	CC	O	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
was	be	VBD	B-VP	O
postponed	postpone	VBN	I-VP	O
until	until	IN	B-SBAR	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
Epogen	Epogen	NN	B-NP	O
therapy	therapy	NN	I-NP	O
since	since	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
Jehovah	Jehovah	NNP	I-NP	O
's	's	POS	B-NP	O
Witness	Witness	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
returned	return	VBD	B-VP	O
on	on	IN	B-PP	O
10/17/97	10/17/97	CD	B-NP	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
times	time	NNS	I-NP	O
two	two	CD	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
perioperative	perioperative	JJ	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
with	with	IN	B-PP	O
inferior	inferior	JJ	B-NP	O
ST	ST	NN	I-NP	O
elevations	elevation	NNS	I-NP	O
and	and	CC	O	O
peak	peak	JJ	B-NP	O
CK	CK	NN	I-NP	O
of	of	IN	B-PP	O
386	386	CD	B-NP	O
and	and	CC	O	O
MB	MB	NN	B-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
8.1	8.1	CD	B-NP	O
.	.	.	O	O

Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
Verapamil	Verapamil	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
loaded	load	VBN	I-VP	O
on	on	IN	B-PP	O
Digoxin	Digoxin	NN	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
converted	convert	VBD	B-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
on	on	IN	B-PP	O
5/4/97	5/4/97	CD	B-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
postoperative	postoperative	JJ	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
gastrointestinal	gastrointestinal	JJ	B-NP	O
distress	distress	NN	I-NP	O
with	with	IN	B-PP	O
epigastric	epigastric	JJ	B-NP	O
burning	burning	NN	I-NP	O
,	,	,	O	O
reflux	reflux	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
constipation	constipation	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
5/4/97	5/4/97	CD	B-NP	O
at	at	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
noted	note	VBD	B-VP	O
worsening	worsen	VBG	I-VP	O
epigastric	epigastric	JJ	B-NP	O
burning	burning	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
sour	sour	JJ	I-NP	O
taste	taste	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
mouth	mouth	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
relieved	relieve	VBN	I-VP	O
with	with	IN	B-PP	O
Maalox	Maalox	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
awakened	awaken	VBN	I-VP	O
from	from	IN	B-PP	O
sleep	sleep	NN	B-NP	O
with	with	IN	B-PP	O
epigastric	epigastric	JJ	B-NP	O
burning	burning	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
back	back	RB	B-ADVP	O
and	and	CC	O	O
palpitations	palpitation	NNS	B-NP	O
.	.	.	O	O

ECG	ECG	NN	B-NP	O
showed	show	VBD	B-VP	O
rapid	rapid	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
125	125	CD	B-NP	O
to	to	TO	B-PP	O
150	150	CD	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Verapamil	Verapamil	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
times	time	NNS	I-NP	O
two	two	CD	B-NP	O
and	and	CC	O	O
converted	convert	VBD	B-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
ST	ST	JJ	B-NP	O
elevations	elevation	NNS	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
F	F	NN	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
Yacull	Yacull	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
complaint	complaint	NN	I-NP	O
of	of	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
paroxysmal	paroxysmal	JJ	B-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
,	,	,	O	O
syncope	syncope	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
presyncope	presyncope	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
Vero	Vero	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
epigastric	epigastric	JJ	B-NP	O
burning	burning	NN	I-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
prior	prior	JJ	I-NP	O
episode	episode	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Maalox	Maalox	NN	B-NP	O
with	with	IN	B-PP	O
relief	relief	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
lying	lie	VBG	I-VP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Normocephalic	Normocephalic	JJ	B-NP	O
,	,	,	I-NP	O
atraumatic	atraumatic	JJ	I-NP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
equal	equal	JJ	B-ADJP	O
,	,	,	O	O
round	round	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
reactive	reactive	JJ	B-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
and	and	CC	I-NP	O
accommodation	accommodation	NN	I-NP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
movements	movement	NNS	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Oropharynx	Oropharynx	NN	B-NP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

Neck	Neck	NNP	B-NP	O
:	:	:	O	O
Supple	Supple	NNP	B-NP	O
.	.	.	O	O

Full	Full	JJ	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
motion	motion	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

Carotids	Carotid	NNS	B-NP	B-protein
2	2	CD	B-NP	I-protein
+	+	SYM	B-NP	O
without	without	IN	B-PP	O
bruits	bruit	NNS	B-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
8	8	CD	I-NP	I-protein
cm	cm	NN	I-NP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
heave	heave	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
thrill	thrill	NN	I-NP	O
.	.	.	O	O

Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
.	.	.	O	O

S1	S1	NN	B-NP	B-protein
,	,	,	I-NP	O
split	split	JJ	I-NP	O
S2	S2	NN	I-NP	O
.	.	.	O	O

2/6	2/6	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
apex	apex	NN	B-NP	O
.	.	.	O	O

Positive	Positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
frictional	frictional	JJ	B-NP	O
rub	rub	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
wheeze	wheeze	NN	I-NP	O
or	or	CC	I-NP	O
rhonchi	rhonchi	NN	I-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
had	have	VBD	B-VP	O
midline	midline	NN	B-NP	O
sternotomy	sternotomy	NN	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
exudate	exudate	NN	I-NP	O
or	or	CC	I-NP	O
erythema	erythema	NN	I-NP	O
.	.	.	O	O

Sternum	Sternum	NNP	B-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

Back	Back	RB	B-ADVP	O
:	:	:	O	O
No	No	DT	B-NP	O
costovertebral	costovertebral	JJ	I-NP	O
angle	angle	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Keloid	Keloid	NN	B-NP	O
in	in	IN	B-PP	O
right	right	JJ	B-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	NN	I-NP	O
.	.	.	O	O

Soft	Soft	RB	B-ADVP	O
,	,	,	O	O
nontender	nontender	JJ	B-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
hepatosplenomegaly	hepatosplenomegaly	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
clubbing	clubbing	NN	I-NP	O
,	,	,	O	O
cyanosis	cyanosis	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
edema	edema	NN	B-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-ADJP	O
:	:	:	O	O
Alert	Alert	NNP	B-NP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
times	time	NNS	B-NP	O
three	three	CD	B-NP	O
.	.	.	O	O

Cranial	Cranial	NNP	B-NP	O
nerves	nerve	VBZ	B-VP	O
II	II	CD	B-NP	O
-	-	HYPH	I-NP	O
XII	XII	CD	I-NP	O
intact	intact	JJ	I-NP	O
.	.	.	O	O

Intact	Intact	JJ	B-NP	O
sensation	sensation	NN	I-NP	O
and	and	CC	I-NP	O
strength	strength	NN	I-NP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

Reflexes	Reflex	NNS	B-NP	O
symmetric	symmetric	JJ	B-ADJP	O
and	and	CC	O	O
toes	toe	VBZ	B-VP	O
downgoing	downgoing	NN	B-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
129	129	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
5.4	5.4	CD	I-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	B-protein
1.0	1.0	CD	I-NP	I-protein
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
20	20	CD	I-NP	I-DNA
,	,	,	O	O
glucose	glucose	NN	B-NP	O
227	227	CD	I-NP	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
level	level	NN	I-NP	O
2.6	2.6	CD	I-NP	O
.	.	.	O	O

Hematocrit	Hematocrit	NN	B-NP	B-protein
45.1	45.1	CD	I-NP	I-protein
,	,	,	O	O
WBC	WBC	NNP	B-NP	O
9.2	9.2	CD	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
triponin-1	triponin-1	NN	I-NP	B-protein
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
0.7	0.7	CD	B-NP	O
.	.	.	O	O

ECG	ECG	NN	B-NP	O
at	at	IN	B-PP	O
Aifield	Aifield	NNP	B-NP	O
Sum	Sum	NNP	I-NP	O
Taning	Taning	NNP	I-NP	O
Healthcare	Healthcare	NNP	I-NP	O
Center	Center	NNP	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
left	left	JJ	I-NP	O
axis	axis	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
intervals	interval	NNS	I-NP	O
.	.	.	O	O

0.16	0.16	CD	B-NP	O
,	,	,	I-NP	O
0.88	0.88	CD	I-NP	O
,	,	,	I-NP	O
0.36	0.36	CD	I-NP	O
.	.	.	O	O

Rate	Rate	NN	B-NP	O
of	of	IN	B-PP	O
85	85	CD	B-NP	O
.	.	.	O	O

Left	Leave	VBN	B-NP	O
atrial	atrial	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
.	.	.	O	O

1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
2	2	CD	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
Digoxin	Digoxin	NN	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
upsloping	upslope	VBG	B-VP	O
ST	ST	JJ	B-NP	O
elevations	elevation	NNS	I-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
,	,	,	I-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
F	F	NN	B-NP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
ECG	ECG	NN	I-NP	O
on	on	IN	B-PP	O
8/28/97	8/28/97	CD	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
mediastinal	mediastinal	JJ	B-NP	O
shadow	shadow	NN	I-NP	O
.	.	.	O	O

Stable	Stable	JJ	B-ADJP	O
with	with	IN	B-PP	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
atelectasis	atelectasis	NN	B-NP	O
at	at	IN	B-PP	O
left	left	JJ	B-NP	O
base	base	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
burning	burning	NN	I-NP	O
was	be	VBD	B-VP	O
primarily	primarily	RB	B-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
gastrointestinal	gastrointestinal	JJ	B-NP	O
reflux	reflux	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
relieved	relieve	VBN	I-VP	O
with	with	IN	B-PP	O
Maalox	Maalox	NNP	B-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
chest	chest	NN	B-NP	O
discomfort	discomfort	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
shoulder	shoulder	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
musculoskeletal	musculoskeletal	JJ	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
relieved	relieve	VBN	I-VP	O
with	with	IN	B-PP	O
Tylenol	Tylenol	NN	B-NP	O
and	and	CC	I-NP	O
Percocet	Percocet	NN	I-NP	O
or	or	CC	I-NP	O
Darvocet	Darvocet	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
monitor	monitor	NN	B-NP	O
she	she	PRP	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
although	although	IN	B-SBAR	O
she	she	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
supraventricular	supraventricular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
incident	incident	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
ten-beat	ten-beat	JJ	I-NP	O
run	run	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
light	light	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
Jehovah	Jehovah	NNP	I-NP	O
's	's	POS	B-NP	O
Witness	Witness	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
a	a	DT	B-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
being	be	VBG	B-VP	O
Coumadinized	Coumadinize	VBN	I-VP	O
for	for	IN	B-PP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
we	we	PRP	B-NP	O
would	would	MD	B-VP	O
use	use	VB	I-VP	O
the	the	DT	B-NP	O
anti-arrhythmic	anti-arrhythmic	JJ	I-NP	O
agent	agent	NN	I-NP	O
,	,	,	O	O
Propafenone	Propafenone	NN	B-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
prevent	prevent	VB	I-VP	O
episodes	episode	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
perioperative	perioperative	JJ	I-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Digoxin	Digoxin	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
Propafenone	Propafenone	NN	B-NP	O
load	load	NN	I-NP	O
of	of	IN	B-PP	O
150	150	CD	B-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	RB	B-ADVP	O
well	well	RB	I-ADVP	O
along	along	IN	B-ADVP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
Verapamil	Verapamil	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
issues	issue	NNS	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
were	be	VBD	B-VP	O
that	that	DT	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugar	sugar	NN	I-NP	O
was	be	VBD	B-VP	O
high	high	JJ	B-ADJP	O
requiring	require	VBG	B-VP	O
sliding	slide	VBG	I-VP	O
scale	scale	NN	B-NP	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
.	.	.	O	O

Also	Also	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
hyponatremia	hyponatremia	NN	B-NP	O
with	with	IN	B-PP	O
sodium	sodium	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
120s	120s	CD	I-NP	O
and	and	CC	O	O
low	low	JJ	B-NP	O
130s	130	NNS	I-NP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
potassium	potassium	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
mildly	mildly	RB	I-VP	O
elevated	elevate	VBN	I-VP	O
,	,	,	O	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
5.0	5.0	CD	B-NP	O
to	to	TO	B-PP	O
5.8	5.8	CD	B-NP	O
.	.	.	O	O

Cortisol	Cortisol	NN	B-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
drawn	draw	VBN	I-VP	O
and	and	CC	O	O
results	result	NNS	B-NP	O
are	be	VBP	B-VP	O
pending	pende	VBG	I-VP	O
for	for	IN	B-PP	O
possibility	possibility	NN	B-NP	O
of	of	IN	B-PP	O
adrenal	adrenal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
renal	renal	JJ	I-NP	B-protein
tubular	tubular	JJ	I-NP	I-protein
acidosis	acidosis	NN	I-NP	I-protein
type	type	NN	I-NP	I-protein
IV	IV	CD	I-NP	I-protein
was	be	VBD	B-VP	O
raised	raise	VBN	I-VP	O
.	.	.	O	O

Throughout	Throughout	IN	B-PP	O
the	the	DT	B-NP	O
admission	admission	NN	I-NP	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
burning	burning	NN	I-NP	O
was	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
Maalox	Maalox	NNP	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Pepcid	Pepcid	NNP	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	JJ	I-NP	O
Helicobacter	Helicobacter	NN	I-NP	O
pylori	pylori	NN	I-NP	O
and	and	CC	I-NP	O
IgG	IgG	NN	I-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
results	result	NNS	B-NP	O
are	be	VBP	B-VP	O
pending	pende	VBG	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
musculoskeletal	musculoskeletal	JJ	I-NP	B-protein
pain	pain	NN	I-NP	I-protein
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
primarily	primarily	RB	B-ADVP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
shoulder	shoulder	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
arm	arm	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
Tylenol	Tylenol	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
history	history	NN	I-NP	O
as	as	IN	B-PP	O
above	above	JJ	B-NP	O
,	,	,	I-NP	O
asthma	asthma	NN	I-NP	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
required	require	VBN	I-VP	O
hospitalization	hospitalization	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
intubations	intubation	NNS	I-NP	O
,	,	,	O	O
adult-onset	adult-onset	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
takes	take	VBZ	B-VP	O
Micronase	Micronase	NN	B-NP	B-protein
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
gastroesophageal	gastroesophageal	JJ	B-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
lobe	lobe	NN	I-NP	O
granuloma	granuloma	NN	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
chest	chest	NN	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
cataracts	cataract	NNS	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q4h	q4h	NN	I-NP	O
,	,	,	O	O
Albuterol	Albuterol	NNP	B-NP	O
inhaler	inhal	JJR	I-NP	O
2	2	CD	I-NP	O
puffs	puff	NNS	I-NP	O
q.i.d.	q.i.d.	RB	B-ADVP	O
,	,	,	O	O
Ecasa	Ecasa	NNP	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Beclovent	Beclovent	NNP	B-NP	O
2	2	CD	I-NP	O
sprays	spray	NNS	I-NP	O
t.i.d.	t.i.d.	RB	B-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Epogen	Epogen	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
,	,	,	I-NP	O
000	000	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
Gliburide	Gliburide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Mevacor	Mevacor	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
Prilosec	Prilosec	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Propafenone	Propafenone	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Verapamil	Verapamil	NNP	B-NP	O
SR	SR	NNP	I-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
Beta	Beta	NN	B-NP	O
blockers	blocker	NNS	I-NP	O
and	and	CC	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
questionable	questionable	JJ	B-ADJP	O
whether	whether	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
allergy	allergy	NN	B-NP	O
to	to	TO	B-VP	O
Naprosyn	Naprosyn	VB	I-VP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
tobacco	tobacco	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
On	On	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
She	She	NNP	I-NP	O
will	will	MD	B-VP	O
likely	likely	RB	I-VP	O
require	require	VB	I-VP	O
a	a	DT	B-NP	O
short	short	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	I-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
returning	return	VBG	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
following	follow	VBG	B-PP	O
her	her	PRP$	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

FOLLOWUP	FOLLOWUP	NN	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow-up	follow-up	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Ruacho	Ruacho	NNP	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Ciccarello	Ciccarello	NNP	I-NP	O
CONDITION	CONDITION	NNP	I-NP	O
ON	ON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
stable	stable	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
ART	ART	NNP	B-NP	O
REIFSNYDER	REIFSNYDER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
LOUIE	LOUIE	NNP	B-NP	O
A.	A.	NNP	I-NP	O
ROGHAIR	ROGHAIR	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
AD2	AD2	NNP	I-NP	O
RM025/7236	RM025/7236	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
9220	9220	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

WMCV4Y199X	WMCV4Y199X	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
4/21/97	4/21/97	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
4/21/97	4/21/97	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

TODD	TODD	NNP	B-NP	O
LILE	LILE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SL26	SL26	.	O	B-cell_line

